Dr. Michael R. Johnson, MD

Dr. Johnson practices at HCA Florida North Florida Hospital in Gainesville, Florida, part of HCA Healthcare.

Dr. Johnson's NPI, 1558477752, was assigned on August 21, 2006. Dr. Johnson graduated from Yale School of Medicine in 1985. Dr. Johnson holds Florida license ME88411.

Dr. Johnson's primary practice is HCA Florida North Florida Hospital, at 6500 W Newberry Rd, Gainesville, FL 32605 in Alachua County. The practice phone is (352) 333-4100.

Dr. Johnson's primary practice is HCA Florida North Florida Hospital in Gainesville, Florida, part of HCA Healthcare. The medical group on file is North Florida Regional Psychiatry. Dmand AI also links Dr. Johnson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Johnson practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Johnson's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Johnson is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Johnson's licenses on file in 3 states: Florida, South Carolina and Colorado.

Dmand AI lists ADHD, alcohol use disorders, anxiety, bipolar disorder, depression, insomnia and schizophrenia among the conditions Dr. Johnson treats.

CMS data shows 319 Medicare services from Dr. Johnson across 3 procedure codes in 2024, all of them office visits, for 151 Medicare patients. Medicare paid $27,985 for them. Every service was in an office.

CMS counts 151 Medicare patients who saw Dr. Johnson in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have anxiety, and 75% have depression. 13% are also on Medicaid. Their average risk score is 1.32, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Johnson's median patient age at 61, with 63% women.

In 2024, Dr. Johnson wrote 730 Medicare Part D claims for 137 patients. 90% of them were for generic drugs. CMS names the drug for 609 of them, across 12 drugs with 11 or more claims each, at $31,457 in total drug cost. In 2023, CMS named 631 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Johnson for performance year 2024, reported as part of a group. Dr. Johnson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Johnson as offering telehealth.

Dmand AI links 15 papers to Dr. Johnson in 2016. The most frequent topics are Anxiety Disorders, Comorbidity and Panic Disorder. Dr. Johnson has published most often in Biol Psychiatry. Dr. Johnson's most frequent co-authors are Courtnay Willcox Bloomer, MD, Jonathan Sam Davidson, MD and Sanjay J. Mathew, MD.

Dmand AI links Dr. Johnson to 3 clinical trials, 2 of them phase 3 studies. Conditions studied include Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders and Headache. Rhodes Pharmaceuticals, L.P. sponsors the most, 2. Open Payments lists research payments to Dr. Johnson that name 1 trial.

CMS Open Payments shows 212 general payments to Dr. Johnson from 21 drug and device companies from 2016 to 2019. Food and beverage make up the largest share, 52% of the total. Allergan Inc. paid the most, $3,047. It also lists 7 research payments totaling $3,145 from 2016 to 2017, naming 1 clinical trial.

Dr. Johnson graduated from Yale School of Medicine in 1985. Dr. Johnson is a member of APA.

Dr. Johnson is in network with 12 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.